Method and composition for enhancing anti-angiogenic therapy

Details for Australian Patent Application No. 2005308539 (hide)

Owner Tiltan Pharma Ltd

Inventors Ben-Sasson, Shmuel A.

Agent Collison & Co

Pub. Number AU-A-2005308539

PCT Pub. Number WO2006/056889

Priority 60/616,348 06.10.04 US

Filing date 5 October 2005

Wipo publication date 1 June 2006

International Classifications

A61K 31/00 (2006.01)

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/056889 Priority application(s): WO2006/056889

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005308543-De-serializing data objects on demand

2005308538-Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders